Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES

NARecruitingINTERVENTIONAL
Enrollment

1,750

Participants

Timeline

Start Date

August 8, 2025

Primary Completion Date

January 10, 2030

Study Completion Date

January 31, 2030

Conditions
CARESStandard of Care
Interventions
BEHAVIORAL

CARES

Integrated screening and stepped collaborative care

BEHAVIORAL

Standard of Care (SOC)

Screening and referral of patient to provider in the community or cancer center

Trial Locations (1)

15213

RECRUITING

University of Pittsburgh Medical Center (UPMC) Cancer Center, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pittsburgh

OTHER

NCT07183527 - Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES | Biotech Hunter | Biotech Hunter